Agilent/$A

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Agilent

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Ticker

$A

Primary listing

NYSE

Industry

Life Sciences Tools & Services

Employees

18,000

ISIN

US00846U1016

Agilent Metrics

BasicAdvanced
$34B
29.37
$4.06
1.23
$0.97
0.83%

What the Analysts think about Agilent

Analyst ratings (Buy, Hold, Sell) for Agilent stock.

Bulls say / Bears say

Agilent Technologies has received a consensus rating of 'Moderate Buy' from analysts, with an average target price of $150.83, indicating potential upside. (marketbeat.com)
The company's forward P/E ratio of 19.31 suggests a reasonable valuation relative to its earnings potential, supported by robust revenue growth of 6.00% and a return on equity of 18.88%. (directorstalkinterviews.com)
Agilent's substantial free cash flow of over $1 billion provides significant liquidity for future projects, dividends, and potential strategic acquisitions. (directorstalkinterviews.com)
Agilent has faced operational challenges, including parts shortages and supply chain disruptions, which could hinder its ability to meet product demand and lead to excess inventory. (finance.yahoo.com)
The company relies heavily on key personnel, and the competitive landscape for recruiting technical talent poses a risk to its ability to maintain and grow its business. (finance.yahoo.com)
Agilent's strategic initiatives to adjust its cost structure, including reorganizations and workforce reductions, may have long-term adverse effects, potentially distracting management and limiting production scalability during periods of increased demand. (finance.yahoo.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.

Agilent Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Agilent Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $A

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jul23
Agilent
Dividend·Payment
$0.248Per share
FAQs